definiens: means, in relation to an obligation of a Party un der this Agreement, efforts and resources comparable to those which an entity in the biotechnology or pharmaceutical indus try of similarresources and expertise as such Party generally use s to accomplish an equivalent task and, if used in relation to theDevelopment, registration, manufacture, use, market ing, distribution, sale and other Commercialization of a product, efforts used by such an entity in relation to its o wn products ( including internally developed, acquir ed and in - licensedproducts ) of a similar market potential or profit p otential at a similar stage in development or produ ct life, based onconditions then prevailing and taking into account, without limitation, issues of safety and efficacy, RegulatoryAuthority - approved labeling, product profile, the c ompetitiveness of alternative products in the marke tplace, the likelytiming of the product ’s entry into the market, the patent and other proprietary position, the likeliho od of RegulatoryApproval and other relevant scientific, technical a nd commercial factors